Trends in Clinical Surveillance & Analytics

Publication Date:           March 2018
Number of Pages:          66
Number of figures:         22
Report Price:                 $995 U.S. Dollars
enterprise pricing available upon request

Recent news coverage
Customer testimonials

Introduction  (download paper overview)

Trends in Clinical Surveillance and Analytics 2018 presents the
findings of an end-user market study identifying the market opportunities
and challenges for hospitals and health systems within the United States
who are developing their strategy or considering making investments in a
real-time clinical surveillance and analytics solutions targeted at
physicians, nurses and other care team members who are concerned
about proactively identifying patients that can experience deteriorating or
life-threatening conditions. This study is not intended to be an evaluation
of existing vendor solutions or strategies.  

Content for
Trends in Clinical Surveillance and Analytics 2018 was
derived from more than thirty (30) clinical informatics thought leaders at
leading hospitals and health systems across the United States who are
technically competent and knowledgeable about the opportunities and
issues of clinical surveillance and related analytics for identifying
deteriorating patient conditions.

The telephone interviews were conducted over a three-month period
starting in November 2017. During the interviews, Spyglass identified the
market requirements for clinical surveillance and analytics tools through
discussions about:
  • workflow inefficiencies in monitoring patients considered at-risk of
    deteriorating or life-threatening conditions,
  • current usage models for clinical surveillance tools, and
  • barriers for widespread clinical surveillance adoption.

Spyglass also evaluated key vendor product offerings and identified
early adopter organizations that have successfully deployed these

Target Audience

  • Software and hardware vendors, systems integrators and
    management consulting groups who are selling hardware,
    applications and services into the healthcare industry
  • Healthcare administrators and IT executives who are making
    strategic decision to fund clinical information technology solutions
  • Clinicians who are involved in informatics and clinical system
    evaluation and selection
  • Investment bankers and private equity investors


Investments. Hospitals and health systems are making investments in
clinical surveillance solutions that enable physicians, nurses and other
care team members to monitor high- and low-acuity patients who can
experience deteriorating or life-threatening conditions. These solutions
are being implemented within different care settings throughout the
hospital including emergency and operating rooms, post-anesthesia
care, intensive care, medical/surgical, and telemetry units.  

Market drivers. Hospitals surveyed are seeking early warning and
predictive indicators to trigger rapid response to deteriorating patient
conditions. Hospitals need new tactics to prevent escalations in patient
care as these negatively affect the patient, staff, and entire health
system. Examples of escalations in patient care include patient transfers
from general care to the ICU and emergent intubations – both of which
increase length of stay and drive costs up considerably.  

Key hospital benefits for clinical surveillance solutions include:
  • improving quality of care and outcomes by enhancing patient
    safety and reducing the risk of hospital-acquired conditions and
    patient’s length of stay,
  • increasing regulatory compliance by following CDC, CMS, and
    Joint Commission guidelines,
  • reducing healthcare costs by avoiding expensive ICU transfers and
    hospital readmissions, and
  • increasing staff satisfaction by providing state-of-the art tools.

Existing deployments. The majority of hospitals surveyed that have
deployed clinical surveillance solutions are leveraging their multi-million
EHR investments as a starting point - focusing on early warning risk
scoring and sepsis detection. EHR-based solutions provide best practice
alerts, built-in decision support, predefined medical order sets, and
retrospective analytical tools that rely upon non-real-time patient data.
EHR-based solutions are not considered best-of-breed, difficult and time
consuming to deploy, and require significant customization of alerts,
templates and tools to mitigate false positive alerts and alert fatigue.  

Next generation tools. Hospitals surveyed believe it is imperative to
evaluate next generation clinical surveillance solutions that can:
  • embrace and extend the their EHR’s capabilities,
  • access real-time clinical and non-clinical data from multiple
    disparate data sources across the organization,
  • customize algorithms to best represent hospital-based protocols,
  • support large sophisticated data models capable of detecting a
    wide range of deteriorating conditions while reducing the signal to
    noise ratio.  

Call to action. Hospitals surveyed have varying levels of understanding
about clinical surveillance and analytics. They want education about next
generation tools and need to know how to utilize them to enhance patient
safety and improve care quality and outcomes.

Hospitals surveyed are also skeptical about overinflated vendor claims
related to early detection and predictive warnings for patients considered
at-risk of deteriorating conditions. Hospitals want vendors to provide:
  • validation through published peer reviewed articles that
    demonstrate the clinical efficacy of their algorithms based on ‘real’
    hospital data, and
  • a means to review and modify their algorithms to best address the
    needs of their clinical environment and protocols. Vendors with
    fixed “one size fits all” algorithms will be forced to expose what is in
    their “black-box”.

Surveillance monitoring strategies are slowly evolving. While
hospitals surveyed have made significant investments in biomedical
monitoring equipment AND have formulated alarm safety committees to
address the Joint Commission’s National Patient Safety Goal, eight-seven
(87) percent of them report that they are still in the earliest stages of
developing a vision and strategy for continuous surveillance monitoring.  

Surveillance monitoring investments driven by regulatory
The majority of hospitals surveyed report that surveillance
monitoring investments are being driven primarily by federal and state
regulatory requirements (such as sepsis) AND secondarily to address the
Joint Commission’s National Patient Safety Goal focused on alarm

Surveillance monitoring investments hampered by an
uneducated buyer
. Forty-seven (47) percent of hospitals surveyed
report that internal personnel have moderate knowledge about
surveillance monitoring solutions. More sophisticated buyers can be
found at academic medical centers who have already deployed an eICU.  
Spyglass Consulting Group
Market Intelligence for Competitive Advantage